00069-1014 BOSULIF - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00069-1014

Brand Name:

BOSULIF

Generic Name:

Bosutinib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: BOSUTINIB MONOHYDRATE

Strength: 100.0

Unit: mg/1

Packages:

Code: 00069-1014-15

Description: 150 CAPSULE in 1 BOTTLE (0069-1014-15)

Effective Date: Jan. 2, 2024

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BCR-ABL

Orphan Drug Designation:

Status:

In Use